{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:20:54Z","timestamp":1789132854378,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T00:00:00Z","timestamp":1368489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-138","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T12:17:53Z","timestamp":1368533873000},"source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study"],"prefix":"10.1186","volume":"13","author":[{"given":"Hideaki","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Fujikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Kanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,14]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68: 241-251. 10.1001\/archgenpsychiatry.2011.12.","journal-title":"Arch Gen Psychiatry"},{"key":"1320_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/NDT.S9932","volume":"7","author":"CL Bowden","year":"2011","unstructured":"Bowden CL: The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder. Neuropsychiatr Dis Treat. 2011, 7: 87-92.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1320_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S1461145709990344","volume":"13","author":"N Cruz","year":"2010","unstructured":"Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valenti M, Vieta E: Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Int J Neuropsychopharmacol. 2010, 13: 5-14. 10.1017\/S1461145709990344.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1320_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","volume":"199","author":"LV Kessing","year":"2011","unstructured":"Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK: Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry. 2011, 199: 57-63. 10.1192\/bjp.bp.110.084822.","journal-title":"Br J Psychiatry"},{"issue":"Suppl 1","key":"1320_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000049259","volume":"45","author":"A Erfurth","year":"2002","unstructured":"Erfurth A, Michael N, Stadtland C, Arolt V: Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiology. 2002, 45 (Suppl 1): 33-36.","journal-title":"Neuropsychobiology"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jad.2010.04.025","volume":"126","author":"M Pilhatsch","year":"2010","unstructured":"Pilhatsch M, Wolf R, Winter C, Lewitzka U, Bauer M: Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study. J Affect Disord. 2010, 126: 453-457. 10.1016\/j.jad.2010.04.025.","journal-title":"J Affect Disord"},{"key":"1320_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","volume":"162","author":"JR Calabrese","year":"2005","unstructured":"Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005, 162: 1351-1360. 10.1176\/appi.ajp.162.7.1351.","journal-title":"Am J Psychiatry"},{"key":"1320_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","volume":"26","author":"ME Thase","year":"2006","unstructured":"Thase ME, Bowden CL, Nashat M, Eudicone JM, Marcus R, McQuade RD, Carlson BX: Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006, 26: 600-609. 10.1097\/01.jcp.0000248603.76231.b7.","journal-title":"J Clin Psychopharmacol"},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hup.1096","volume":"25","author":"A Quante","year":"2010","unstructured":"Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, Anghelescu I, Wolf J: Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol. 2010, 25: 126-132. 10.1002\/hup.1096.","journal-title":"Hum Psychopharmacol"},{"issue":"Suppl 1","key":"1320_CR10","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0165-0327(11)70005-2","volume":"128","author":"LN Yatham","year":"2011","unstructured":"Yatham LN: A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder. J Affect Disord. 2011, 128 (Suppl 1): S21-S28.","journal-title":"J Affect Disord"},{"key":"1320_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","volume":"28","author":"ME Thase","year":"2008","unstructured":"Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R: Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol. 2008, 28: 13-20. 10.1097\/jcp.0b013e3181618eb4.","journal-title":"J Clin Psychopharmacol"},{"key":"1320_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4088\/JCP.09m05934","volume":"72","author":"GS Sachs","year":"2011","unstructured":"Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B: Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011, 72: 1413-1422. 10.4088\/JCP.09m05934.","journal-title":"J Clin Psychiatry"},{"key":"1320_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003, 60: 1079-1088. 10.1001\/archpsyc.60.11.1079.","journal-title":"Arch Gen Psychiatry"},{"key":"1320_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1192\/bjp.bp.112.108357","volume":"201","author":"M Tohen","year":"2012","unstructured":"Tohen M, McDonnell DP, Case M, Kanba S, Ha K, Fang YR, Katagiri H, Gomez JC: Randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Br J Psychiatry. 2012, 201: 376-382. 10.1192\/bjp.bp.112.108357.","journal-title":"Br J Psychiatry"},{"key":"1320_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979, 134: 382-389. 10.1192\/bjp.134.4.382.","journal-title":"Br J Psychiatry"},{"key":"1320_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960, 23: 56-62. 10.1136\/jnnp.23.1.56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1320_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435. 10.1192\/bjp.133.5.429.","journal-title":"Br J Psychiatry"},{"key":"1320_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","volume":"73","author":"MK Spearing","year":"1997","unstructured":"Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997, 73: 159-171. 10.1016\/S0165-1781(97)00123-6.","journal-title":"Psychiatry Res"},{"key":"1320_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","volume":"11","author":"M Tohen","year":"2009","unstructured":"Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M: The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009, 11: 453-473. 10.1111\/j.1399-5618.2009.00726.x.","journal-title":"Bipolar Disord"},{"key":"1320_CR20","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/mds.10255","volume":"17","author":"JH Kim","year":"2002","unstructured":"Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS: Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders. Mov Disord. 2002, 17: 1354-1359. 10.1002\/mds.10255.","journal-title":"Mov Disord"},{"issue":"Suppl 20","key":"1320_CR21","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59 (Suppl 20): 22-33.","journal-title":"J Clin Psychiatry"},{"key":"1320_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/13651501.2011.632680","volume":"16","author":"ME Thase","year":"2012","unstructured":"Thase ME, Bowden CL, Nashat M, Eudicone JM, Marcus R, McQuade RD, Carlson BX: Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms. Int J Psychiatry Clin Pract. 2012, 16: 121-131. 10.3109\/13651501.2011.632680.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"1320_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00213-002-1147-6","volume":"163","author":"P Bech","year":"2002","unstructured":"Bech P, Tanghoj P, Andersen HF, Overo K: Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacology (Berl). 2002, 163: 20-25. 10.1007\/s00213-002-1147-6.","journal-title":"Psychopharmacology (Berl)"},{"key":"1320_CR24","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.4088\/JCP.08m04772gre","volume":"70","author":"F Benazzi","year":"2009","unstructured":"Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M: Olanzapine\/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J Clin Psychiatry. 2009, 70: 1424-1431. 10.4088\/JCP.08m04772gre.","journal-title":"J Clin Psychiatry"},{"key":"1320_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/schbul\/sbn110","volume":"36","author":"AS Kemp","year":"2010","unstructured":"Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Dub\u00e9 S, Ereshefsky L, Gharabawi G, Leon AC, Lepine JP, Potkin SG, Vermeulen A: What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?. Schizophr Bull. 2010, 36: 504-509. 10.1093\/schbul\/sbn110.","journal-title":"Schizophr Bull"},{"key":"1320_CR26","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","volume":"287","author":"BT Walsh","year":"2002","unstructured":"Walsh BT, Seidman SN, Sysko R, Gould M: Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002, 287: 1840-1847. 10.1001\/jama.287.14.1840.","journal-title":"JAMA"},{"key":"1320_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jad.2011.10.045","volume":"136","author":"H Katagiri","year":"2012","unstructured":"Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M: Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study. J Affect Disord. 2012, 136: 476-484. 10.1016\/j.jad.2011.10.045.","journal-title":"J Affect Disord"},{"key":"1320_CR28","unstructured":"Zyprexa [package insert]. 2008, Indianapolis, IN: Eli Lilly and Company"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-138\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T01:24:26Z","timestamp":1468373066000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-138","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,14]]},"article-number":"138"}}